Sigilon Therapeutics (SGTX) Competitor Comparison
We are evaluating the key criteria listed to compare Sigilon Therapeutics (SGTX) against its competitors in the Biotechnology industry.
Market Capitalization
288 / 368Gross Profits
176 / 278Total Revenue
0 / 300EBITDA
0 / 337Free Cashflow
0 / 352Quick Ratio
0 / 357Earnings per Share
0 / 359Dividend yield
0 / 6Total Cash
0 / 358Performance 3 years
311 / 368Performance 5 years
285 / 368Performance 10 years
249 / 368Linearity 3 years
311 / 368Linearity 5 years
313 / 368Linearity 10 years
283 / 367Total Rank
263 / 368Dividend Rank
272 / 368Valuation Rank
231 / 368Piotroski Rank
178 / 368Muliplier Rank
207 / 368Market Capitalization - SGTX ranking 288 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.